Appropriate surfactant usage in 1996.

Recent advances in neonatology. Arch Dis Child Fetal Neonatal Ed (1999) 1.40

Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant. Lancet (1992) 6.02

A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med (1991) 2.56

Pulmonary surfactant therapy. N Engl J Med (1993) 2.22

Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. The Members of the National Institute of Child Health and Human Development Neonatal Research Network. Pediatrics (1993) 1.86

Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics (1992) 1.71

Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J Pediatr (1991) 1.59

Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics (1993) 1.57

Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics (1993) 1.57

Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med (1994) 1.51

Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity. J Clin Invest (1988) 1.44

Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics (1996) 1.42

Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med (1994) 1.42

The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Investigators of the Vermont-Oxford Trials Network Database Project. Pediatrics (1993) 1.26

A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr (1993) 1.18

Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest (1981) 1.17

Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child (1993) 1.16

Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation. Pediatr Res (1978) 1.13

Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis (1987) 1.06

Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome. J Pediatr (1993) 1.06

Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA. Eur J Pediatr (1988) 1.02

Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Pediatrics (1993) 1.01

Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol (1985) (1993) 0.95

Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr (1993) 0.95

Lung function in prematurely delivered rabbits treated with a synthetic surfactant. Am Rev Respir Dis (1987) 0.91

Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol (1985) (1994) 0.90

Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Pediatrics (1991) 0.90

Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome. Pediatrics (1990) 0.87

Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses. The French Collaborative Multicentre Study Group. Acta Paediatr (1995) 0.87

Surfactant inhibition in experimental meconium aspiration. Acta Paediatr (1993) 0.86

The role of surfactant-associated proteins. Am Rev Respir Dis (1990) 0.82

Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration. Biol Neonate (1993) 0.81

Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant. Survanta Multidose Study Group. J Pediatr (1994) 0.78

A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network. Pediatrics (1996) 0.78

Treatment Investigational New Drug experience with Survanta (beractant). Pediatrics (1993) 0.78

Surfactant therapy in the USA: trials and current routines. Biol Neonate (1997) 0.79